APOA2 and exocrine pancreatic carcinoma: In particular, the association of apoA-II alterations with pancreatic cancer is valuable since the detection of early-stage pancreatic cancer of non-symptomatic patients by harmless strategies is imperative to reduce the mortality due to this devastating pancreatic carcinoma.